Hans Hull's Net Worth
$6.74 Million
Who is Hans Hull?
Hans Hull has an estimated net worth of $6.74 Million. This is based on reported shares across multiple companies, which include PLIANT THERAPEUTICS, INC., and Avalanche Biotechnologies, Inc..
SEC CIK
Hans Hull's CIK is 0001614876
Past Insider Trading and Trends
2015 was Hans Hull's most active year for acquiring shares with 7 total transactions. Hans Hull's most active month to acquire stocks was the month of December. 2015 was Hans Hull's most active year for disposing of shares, totalling 8 transactions. Hans Hull's most active month to dispose stocks was the month of July. 2023 saw Hans Hull paying a total of $58,029.28 for 195,325 shares, this is the most they've acquired in one year. In 2015 Hans Hull cashed out on 77,300 shares for a total of $1,291,205.17, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $12.87
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.17% | -9.90K |
$11.56 | -$114,444.00 | 227.49K |
Scheduled
|
Jul 10
| ||
Form 4
| +8.87% | 19.34K |
—
|
—
| 237.39K |
Jul 9
| |||
Form 4
| +17.02% | 31.5K |
—
|
—
| 216.57K |
Jan 23
| |||
Form 4
| -5.02% | -9.79K |
$17.23 | -$168,612.78 | 185.07K |
Scheduled
|
Jan 17
| ||
Form 4
| -9.46% | -20.73K |
$12.35 | -$604,551.22 | 194.85K |
Aug 3 - Aug 4
| |||
Form 4
| -7.56% | -17.94K |
$18.01 | -$323,029.23 | 219.18K |
Jul 17
| |||
Form 4
| +17.41% | 35.16K |
—
|
—
| 237.12K |
Jul 14
| |||
Form 4
| -4.28% | -9.04K |
$26.52 | -$239,642.85 | 201.96K |
Mar 30
| |||
Form 4
| +9.09% | 17.58K |
—
|
—
| 211K |
Mar 29
| |||
Form 4
| +39.08% | 54K |
—
|
—
| 192.19K |
Jan 25
| |||
Form 4
| +6.83% | 8.83K |
$19.10 | -$167,107.80 | 138.19K |
Dec 19 - Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| +3.73% | 4.5K |
$2.08 | $9,360.00 | 125.25K |
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +2.99% | 3.5K |
$2.08 | $7,280.00 | 120.75K |
Dec 30
| |||
Form 4
| +7.93% | 8.9K |
—
|
—
| 121.07K |
Feb 28 - Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avalanche Biotechnologies, Inc. (ADVM) Snapshot price: $6.76
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +599.34% | 117.59K |
—
|
—
| 137.21K |
Aug 21
| |||
Form 4
| +73.32% | 8.3K |
$0.19 | $1,577.00 | 19.62K |
Jun 12
| |||
Form 4
|
—
|
0
|
$18.92 | -$74,903.20 | 11.32K |
Scheduled
|
Jun 4
| ||
Form 4
|
—
|
0
|
$15.53 | -$153,399.00 | 11.32K |
Scheduled
|
May 4
| ||
Form 4
| +240.96% | 8K |
—
|
—
| 11.32K |
Apr 21
| |||
Form 4
|
—
|
0
|
$19.40 | -$1,056,347.96 | 3.32K |
Scheduled
|
Apr 7
| ||
Form 4
|
∞
| 3.32K |
—
|
—
| 3.32K |
Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||